Clinical Trial Update: Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ursodeoxycholic acid in patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Tanta University | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED